• 1
    Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus: Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339: 7928.
  • 2
    Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59: 20510.
  • 3
    Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology 1988;38: 395400.
  • 4
    Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43: 14653.
  • 5
    Hesdorffer DC, Stables JP, Hauser WA, et al. Are certain diuretics also anticonvulsants Ann Neurol 2001;50: 45862.
  • 6
    Hochman DW, Baraban SC, Owens JW, et al. Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science 1995;270: 99102.
  • 7
    Gutschmidt KU, Stenkamp K, Buchheim K, et al. Anticonvulsant actions of furosemide in vitro. Neuroscience 1999;91: 147181.
  • 8
    Holtkamp M, Tong X, Walker MC. Propofol in subanesthetic doses terminates status epilepticus in a rodent model. Ann Neurol 2001;49: 2603.
  • 9
    Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res 2000;42: 11722.
  • 10
    Prasad A, Williamson JM, Bertram EH. Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann Neurol 2002;51: 17581.
  • 11
    Kaplan PW. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999;16: 34152.
  • 12
    Aminoff MJ. Do nonconvulsive seizures damage the brain?–No. Arch Neurol 1998;55: 11920.
  • 13
    Walker MC, Perry H, Scaravilli F, et al. Halothane as a neuroprotectant during constant stimulation of the perforant path. Epilepsia 1999;40: 35964.
  • 14
    Racine RJ. Modification of seizure activity by electrical stimulation, II: motor seizure. Electroencephalogr Clin Neurophysiol 1972;32: 28194.
  • 15
    Lee VC, Moscicki JC, DiFazio CA. Propofol sedation produces dose-dependent suppression of lidocaine-induced seizures in rats. Anesth Analg 1998;86: 6527.
  • 16
    Hankey GJ, Stewart-Wynne EG. Management of non-convulsive status epilepticus. Lancet 1987;1: 1427.
  • 17
    Stringer JL, Pan E. Effect of seizures and diuretics on the osmolality of the cerebrospinal fluid. Brain Res 1997;745: 32830.
  • 18
    Heltovics G, Boda B, Szente M. Anticonvulsive effect of urethane on aminopyridine-induced epileptiform activity. Neuroreport 1995;6: 57780.
  • 19
    Torbati D, Ramirez J, Hon E, et al. Experimental critical care in rats: gender differences in anesthesia, ventilation, and gas exchange. Crit Care Med 1999;27: 187884.
  • 20
    Budavari S. The Merck Index: an encyclopedia of chemicals, drugs, and biologicals. 12th ed. Whitehouse Station : Merck Research Laboratories , 1996.
  • 21
    Kaplan PW. No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: “the cure may be worse than the disease”). Neurophysiol Clin 2000;30: 37782.
  • 22
    Meierkord H, Grunig F, Gutschmidt U, et al. Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition. Naunyn Schmiedebergs Arch Pharmacol 2000;361: 2532.
  • 23
    Javaheri S, Corbett W, Adams JM, et al. Acute respiratory acidosis: large-dose furosemide and cerebrospinal fluid ions. J Appl Physiol 1994;76: 26515.
  • 24
    Correale J, Rabinowicz AL, Heck CN, et al. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology 1998;50: 138891.